BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29903529)

  • 1. Intestinal microbiota assessment in cirrhotic patients from a Mexican mestizo population.
    Pérez-Monter C; Escalona-Nandez I; Estanes-Hernández A; Noriega-López LG; Torre-Delgadillo A
    Rev Gastroenterol Mex (Engl Ed); 2019; 84(1):26-35. PubMed ID: 29903529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in the gut microbiota and the efficacy of adjuvant probiotic therapy in liver cirrhosis.
    Wu Z; Zhou H; Liu D; Deng F
    Front Cell Infect Microbiol; 2023; 13():1218552. PubMed ID: 37483387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients With Cirrhosis.
    Bajaj JS; Vargas HE; Reddy KR; Lai JC; O'Leary JG; Tandon P; Wong F; Mitrani R; White MB; Kelly M; Fagan A; Patil R; Sait S; Sikaroodi M; Thacker LR; Gillevet PM
    Clin Gastroenterol Hepatol; 2019 Mar; 17(4):756-765.e3. PubMed ID: 30036646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients.
    Lu H; Wu Z; Xu W; Yang J; Chen Y; Li L
    Microb Ecol; 2011 Apr; 61(3):693-703. PubMed ID: 21286703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration.
    Sarangi AN; Goel A; Singh A; Sasi A; Aggarwal R
    BMC Gastroenterol; 2017 Nov; 17(1):125. PubMed ID: 29179682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study.
    Crespo-Salgado J; Vehaskari VM; Stewart T; Ferris M; Zhang Q; Wang G; Blanchard EE; Taylor CM; Kallash M; Greenbaum LA; Aviles DH
    Microbiome; 2016 Sep; 4(1):50. PubMed ID: 27640125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal fecal microbiota community and functions in patients with hepatitis B liver cirrhosis as revealed by a metagenomic approach.
    Wei X; Yan X; Zou D; Yang Z; Wang X; Liu W; Wang S; Li X; Han J; Huang L; Yuan J
    BMC Gastroenterol; 2013 Dec; 13():175. PubMed ID: 24369878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale survey of gut microbiota associated with MHE Via 16S rRNA-based pyrosequencing.
    Zhang Z; Zhai H; Geng J; Yu R; Ren H; Fan H; Shi P
    Am J Gastroenterol; 2013 Oct; 108(10):1601-11. PubMed ID: 23877352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood Microbiome Quantity and the Hyperdynamic Circulation in Decompensated Cirrhotic Patients.
    Traykova D; Schneider B; Chojkier M; Buck M
    PLoS One; 2017; 12(2):e0169310. PubMed ID: 28146577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and Clinical Significance of Intestinal Microbiota in Patients with Chronic Hepatitis B Cirrhosis and Type 2 Diabetes Mellitus.
    Sun X; Chi X; Zhao Y; Liu S; Xing H
    J Diabetes Res; 2022; 2022():1826181. PubMed ID: 35601017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between intestinal microbial dysbiosis and primary liver cancer.
    Zhang L; Wu YN; Chen T; Ren CH; Li X; Liu GX
    Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):149-157. PubMed ID: 30661942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.
    Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA
    World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.
    Schwimmer JB; Johnson JS; Angeles JE; Behling C; Belt PH; Borecki I; Bross C; Durelle J; Goyal NP; Hamilton G; Holtz ML; Lavine JE; Mitreva M; Newton KP; Pan A; Simpson PM; Sirlin CB; Sodergren E; Tyagi R; Yates KP; Weinstock GM; Salzman NH
    Gastroenterology; 2019 Oct; 157(4):1109-1122. PubMed ID: 31255652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mosapride Stabilizes Intestinal Microbiota to Reduce Bacterial Translocation and Endotoxemia in CCl
    Xu H; Xiong J; Xu J; Li S; Zhou Y; Chen D; Cai X; Ping J; Deng M; Chen J
    Dig Dis Sci; 2017 Oct; 62(10):2801-2811. PubMed ID: 28815345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High throughput sequencing reveals distinct microbial populations within the mucosal and luminal niches in healthy individuals.
    Ringel Y; Maharshak N; Ringel-Kulka T; Wolber EA; Sartor RB; Carroll IM
    Gut Microbes; 2015; 6(3):173-81. PubMed ID: 25915459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in bacterial communities, SCFA and biomarkers in an elderly HIV-positive and HIV-negative population in western Mexico.
    González-Hernández LA; Ruiz-Briseño MDR; Sánchez-Reyes K; Alvarez-Zavala M; Vega-Magaña N; López-Iñiguez A; Díaz-Ramos JA; Martínez-Ayala P; Soria-Rodriguez RA; Ramos-Solano M; Andrade-Villanueva JF
    BMC Infect Dis; 2019 Mar; 19(1):234. PubMed ID: 30845929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of mosapride on gut microbiota of carbon tetrachloride-induced cirrhosis rats based on 16S rRNA gene sequencing.
    Chen D; Xiong J; Feng H; Liu Y; Xu J; Xu H
    Adv Clin Exp Med; 2022 Jun; 31(6):623-633. PubMed ID: 35275452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ascitic Bacterial Composition Is Associated With Clinical Outcomes in Cirrhotic Patients With Culture-Negative and Non-neutrocytic Ascites.
    Chen Y; Guo J; Shi D; Fang D; Chen C; Li L
    Front Cell Infect Microbiol; 2018; 8():420. PubMed ID: 30555804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity.
    Nistal E; Sáenz de Miera LE; Ballesteros Pomar M; Sánchez-Campos S; García-Mediavilla MV; Álvarez-Cuenllas B; Linares P; Olcoz JL; Arias-Loste MT; García-Lobo JM; Crespo J; González-Gallego J; Jorquera Plaza F
    Rev Esp Enferm Dig; 2019 Apr; 111(4):275-282. PubMed ID: 30810328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative analysis of intestinal microbiota distribution characteristics based on metagenomics in patients with hepatitis B cirrhosis with or without ascites].
    Luan YT; Liu CH; Jiang SL; Gu HT; Lyu J; Xing F; Zhao CQ; Yuan JL; Liu P; Mu YP
    Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):974-985. PubMed ID: 37872094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.